Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Dr. Bob who wrote (1680)	10/23/1998 1:54:00 PM
From: KIC	Respond to of 2205

LIFC was recently mentioned as one of Individual Investor's 10 stand-out biotechs. One would imagine that this would have an impact on price. However, volume has remained somewhat constant which would indicate that this is not the case. Plotting their recent price movement versus the NASDAQ index provides a more viable explanation.

To: Dr. Bob who wrote (1680)	10/26/1998 11:42:00 PM
From: Marshall Teitelbaum	Read Replies (1) \| Respond to of 2205

Bob, They all have slightly differently slants on their techniques, although with different cosmetic approaches. However, ATIS generally seems to be looking at products with extremely large markets, so if they come to fruition all would look good ( cartilage, gene therapy organs, cardiovascular applications, etc....in addition to skin, of course). There was a front page article today in the Miami Herald entitled: Hope for ailing limbs: artificial skin The primary focus was on apligraf of ORG's, with the main reason being the association with the Univ. of Miami. One interesting comment was that "so far, Novartis has received no reports of insurers refusing to pay, and federal health plan for the elderly, Medicare, covers it". Also, much other use other than venous stasis ulcers was mentioned.........any comments? Looks like technically it is brushing up with 3 again, and there was a slightly higher amount of trading today, especially with a flurry at the end, with a later day very large trade of what I believe was over 40,000 shares. Still, only @1500 shares per trade, and exactly 200 trades today. Can't quite get over the 3 hump, and until it does, it is left stuck in the 2 3/4-3 trading range, barring reason to move lower, or simply year-end tax selling, which is possible, but I have trouble seeing it go much lower without bad news or another sector selloff. Looked like ORG and ATIS were both strong today, possibly because of the article. Regards, Marshall